Biopharmaceutical manufacturer of a drug product for thyroid eye disease.
Issues related to pharmaceutical drugs; Issues related to drug pricing; Issues related to drug pricing in H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Medicare Part D; Issues related to policies affecting biopharma products coverage and access in Medicare and Medicaid. Issues regarding the improvement of patient access to advanced rare disease therapies.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
BARRETT THORNHILL JEFFREY FORBES DERRICK M WHITE ELIZABETH GREER CYNTHIA BROWN BARRETT THORNHILL JEFFREY FORBES DERRICK M WHITE ELIZABETH GREER CYNTHIA BROWN